|
|
|
24.03.26 - 15:18
|
China′s WeRide eyes Hong Kong, Singapore roads for robotaxis as self-driving giants expand (SCMP)
|
|
|
Chinese self-driving technology developers continue to expand outside the mainland as WeRide seeks to launch robotaxi services this year in Hong Kong and Singapore, according to an executive.
WeRide's planned entry into Hong Kong was set to cover both robotaxis and robobuses, said senior director of public relations and marketing Maeve Zhang in a media briefing on Tuesday, without disclosing the operation areas or a launch date.
Meanwhile, the Guangzhou-based company said it planned to launch......
|
|
|
24.03.26 - 14:30
|
US move to ban Chinese routers as part of onshoring push could be uphill battle: analysts (SCMP)
|
|
|
A US move to ban imports of new foreign-made consumer routers aims to pressure Chinese manufacturers to “onshore” parts of their production chain, although that will be a challenge given limited US manufacturing capacity, according to analysts.
The US Federal Communications Commission (FCC) said on Monday that it had updated its Covered List to include consumer-grade routers produced in foreign countries, citing concerns that the devices could “pose unacceptable risks to the national security of......
|
|
|
|
|
|
|
|
|
24.03.26 - 13:00
|
Why DHL is betting on rising Chinese exports – even as war and tariff risks grow (SCMP)
|
|
|
Global trade flows are facing severe disruption amid the US-Israel war on Iran and unpredictable tariff policies. But logistics giant DHL still expects its revenues to soar in the coming years thanks in large part to Chinese companies' rising global ambitions.
The resilience of China's outbound trade is a major reason DHL has maintained such an ambitious growth target even amid the Middle East crisis and constantly changing trade barriers, according to Oscar de Bok, CEO of the firm's global......
|
|
|
|
|
24.03.26 - 11:54
|
Philippines′ Marcos on China Relations, Iran War, Economy (Bloomberg)
|
|
|
Philippine President Ferdinand Marcos Jr. believes the country can achieve a GDP growth rate of above 6%, driven by investment, particularly in the semiconductor industry and data centers. He sat down to speak exclusively with Bloomberg's Haslinda Amin in Manila. (Source: Bloomberg)...
|
|
|
24.03.26 - 11:30
|
Xiaomi profit drops 27% on weaker smartphone sales as Chinese firm′s EV growth slows (SCMP)
|
|
|
Xiaomi, the Chinese smartphone and electric vehicle (EV) maker, reported that fourth-quarter net profit dropped 27 per cent from a year earlier, as weaker sales cut into margins.
Profit fell to 6.5 billion yuan (US$943 million), a 47 per cent plunge from the previous quarter and the lowest quarterly number in a year. It was also the first quarter-on-quarter decline since the second quarter of 2024.
Fourth-quarter revenue rose 7.3 per cent from a year earlier and 3 per cent compared with the......
|
|
|
|
|
|
|
24.03.26 - 10:18
|
China EV makers gain as Iran war drives up fuel costs (SCMP)
|
|
|
Chinese petrol prices rose the most since 2000, even after unprecedented government intervention, as the war in Iran upends global oil markets.
Petrol went up by 1,160 yuan (US$169) per tonne at the end of Monday and diesel prices rose by 1,115 yuan, according to the National Development and Reform Commission (NDRC). The increases would have been about twice as high had the usual pricing rules been followed, it said.
The roughly 11 per cent increases, the fifth this year, came after Iran closed......
|
|
|
|
|
24.03.26 - 09:50
|
Philippines′ Marcos Says War May Spur Energy Talks With China (Bloomberg)
|
|
|
Philippine President Ferdinand Marcos Jr.is open to restarting talks with Beijing on a joint oil and gas project in a disputed area of the South China Sea, saying the war in Iran may provide the impetus for a breakthrough. He spoke with Bloomberg's Haslinda Amin in Manila. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
24.03.26 - 08:54
|
Rights to antibody drug by China′s Keymed change hands in Gilead acquisition of Ouro (SCMP)
|
|
|
US biopharmaceutical company Gilead Sciences agreed to buy Ouro Medicines, which is developing an antibody-based medicine for autoimmune diseases licensed from China's Keymed Biosciences, in a deal worth up to US$2.18 billion.
Gilead Sciences is among a group of global drug makers facing patent expirations and turning to mergers, acquisitions and licensing deals to refill their drug pipelines.
Under the agreement, Gilead Sciences would pay shareholders of US-based Ouro Medicines US$1.675 billion......
|
|
|
|
|
|
Top- News zu China 14492.9235 -0.22% (China A50 Kurs)
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
